Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Surovatamig's trials
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Surovatamig
Ongoing
Recruiting
Phase 3
Open NCT06549595 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
NCT06549595 · Trial Tracker · ComplyRx
